Health and Healthcare
Health and Healthcare Articles
Aytu Bioscience has moved very quickly, both to execute agreements for products that can have an impact on the COVID-19 pandemic and to raise the capital it will take to provide a return on...
Published:
Deaths Create Concerns About White House Estimates; the Future of Europe According to the Bing COVID-19 Tracker, global cases have reached 3,193,886. Active cases totaled 1,993,529, which is higher...
Published:
U.S. Deaths Surge Toward 59,000, Blast Through Early Estimate According to the Bing COVID-19 Tracker, global cases have reached 3,117,880. Active cases totaled 1,968,138, which is up 37,480 in a day....
Published:
Merck and Pfizer reported their most recent quarterly results before the opening bell Tuesday. Although markets appear to be recovering, investors were not thrilled about this quarter for these two...
Published:
SmileDirectClub shares pushed higher on Tuesday after the company announced that it had received a patent for its new retail plan.
Published:
Last Updated:
iBio has provided an update on its COVID-19 vaccine manufacturing capacity and said that it has joined the National Institute for Innovation in Manufacturing Biopharmaceuticals.
Published:
Amarin has two big problems. Getting an unfavorable court decision overruled is by far the more important.
Published:
Global Cases Top 3 Million as U.S. Cases Rise Above 1 Million According to the Bing COVID-19 Tracker, global cases have reached 3,042,444. Active cases totaled 1,936,654, which is up by 43,412 in a...
Published:
Pharmaceutical giants Merck and Pfizer are expected to report their most recent quarterly results before the opening bell Tuesday.
Published:
As there is currently no FDA-approved treatment for Alzheimer’s agitation, any progress here could be lucrative. Axsome Therapeutics has announced a big step forward in its midstage Alzheimer’s...
Published:
Aytu BioScience shares made an incredible gain to start the week following the firm’s announcement in regards to a coronavirus treatment.
Published:
The April 15 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
Published:
The April 15 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Published:
Goldman Sachs analysts are bullish on these four top biotech stocks in front of first-quarter results. None of these companies is a proverbial one-trick pony, and they all are potential takeover...
Published:
Outpatient visits to doctor offices are off as much as 60% nationwide. Many doctors will end up closing their businesses and retiring.
Published:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.